A recent research report from CITIC Securities highlights the rising visibility of L-ergothioneine, spurred by media coverage of Kelun Pharmaceutical’s chairman personally endorsing the company’s product. Recognized as a fifth-generation antioxidant, L-ergothioneine is a notable new ingredient derived from synthetic biology, with superior properties and premium pricing compared to competing products. The report forecasts strong long-term growth for synthetic biology-based ingredients amid ongoing technological advancements and regulatory easing, recommending investment in related suppliers.
(Source: 36Kr)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE